Considerable sudden death in hypertrophic cardiomyopathy

Considerable sudden death in hypertrophic cardiomyopathy

(HealthDay)—Patients with hypertrophic cardiomyopathy (HC) without traditional risk factors and with no or mild symptoms have a considerable rate of sudden cardiac death, according to a study published in the May 1 issue of The American Journal of Cardiology.

Paolo Spirito, M.D., from the Ente Ospedaliero Ospedali Galliera in Genoa, Italy, and colleagues examined the risk of in a cohort of 653 with HC, without and with no or mild symptoms. Patients were followed for a median of 5.3 years.

The researchers found that 5.4 percent of the participants died of HC-related causes during follow-up. The mean age of death was 46 years for patients who died suddenly, 66 years for patients who died of , and 72 years for patients who died of stroke. For , heart failure death, and stroke-related death, the event rate was 0.6, 0.2, and 0.1 percent per year, respectively. There was an inverse and independent correlation for sudden death risk with age; heart failure and stroke risk correlated directly with age (P = 0.020). Sudden death risk was 5.9 percent at 10 years after the initial evaluation, with patients with normal left atrial dimension (≤40 mm) having the lowest risk (0.3 percent).

"In conclusion, in our patients with HC with no conventional risk factors and no or mild symptoms, the rate of sudden death proved to be more common than expected (0.6 percent per year)," the authors write.

One author disclosed financial ties to GeneDx and Medtronic.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Scientists solve sudden cardiac death mystery

18 hours ago

(Medical Xpress)—Scientists have discovered the cause of sudden cardiac death in young children, for the first time making it possible to pinpoint a therapeutic target for future efforts in developing a ...

Physicians deactivate heart pump with catheter-based approach

20 hours ago

Donna Jackson's heart, on the verge of failing two years earlier, had made a strong recovery. By spring 2013, she no longer needed the left ventricular assist device, or LVAD, that had been implanted in her chest almost three ...

User comments